Truist Financial
AMED

Truist Financial’s Amedisys AMED Stock Holding History

Truist Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,381
Closed -$218K – 2581
2023
Q2 		$218K Sell
2,381
-403
-14% -$33.1K ﹤0.01% 2411
2023
Q1 		$205K Buy
+2,784
New +$241K ﹤0.01% 2415
2022
Q4 		– Sell
-2,961
Closed -$287K – 2558
2022
Q3 		$287K Buy
2,961
+223
+8% +$26.6K ﹤0.01% 2110
2022
Q2 		$288K Buy
2,738
+40
+1% +$5.11K ﹤0.01% 2241
2022
Q1 		$465K Buy
2,698
+93
+4% +$13.9K ﹤0.01% 2047
2021
Q4 		$422K Buy
2,605
+512
+24% +$82.3K ﹤0.01% 2116
2021
Q3 		$312K Sell
2,093
-1,046
-33% -$217K ﹤0.01% 2327
2021
Q2 		$769K Buy
3,139
+308
+11% +$80.8K ﹤0.01% 1794
2021
Q1 		$750K Sell
2,831
-153
-5% -$43.1K ﹤0.01% 1745
2020
Q4 		$875K Buy
2,984
+731
+32% +$187K ﹤0.01% 1548
2020
Q3 		$533K Buy
+2,253
New +$512K ﹤0.01% 1698
2020
Q2 		– Sell
-1,898
Closed -$349K – 2409
2020
Q1 		$349K Buy
1,898
+139
+8% +$24.7K ﹤0.01% 1766
2019
Q4 		$294K Buy
+1,759
New +$262K ﹤0.01% 2161

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Truist Financial's AMED Position: Q3 2023 in Review

Truist Financial sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,381 shares — an estimated $218K sold.

Truist Financial first reported a position in AMED in Q4 2019 and held it in 13 quarters. The position peaked at $875K in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Truist Financial reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Truist Financial sold 2,381 Amedisys shares in Q3 2023, an estimated $218K.
  • Truist Financial first reported a position in Amedisys in Q4 2019 and held it in 13 quarters.
  • Truist Financial's Amedisys position peaked at $875K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Truist Financial's 13F filing for Q3 2023, filed 14 Nov 2023.